Brain health after 40: what counts as a meaningful benefit?
Blueberries, neurofeedback and Alzheimer’s treatments reveal why a measurable improvement needs careful interpretation before it becomes a brain-health claim.
Deep dives into the science of aging, longevity research, and evidence-based anti-aging strategies. Covering senescent cells, telomere biology, NAD+ pathways, and caloric restriction, these articles help you understand and actively slow the aging process based on the latest scientific discoveries.
Blueberries, neurofeedback and Alzheimer’s treatments reveal why a measurable improvement needs careful interpretation before it becomes a brain-health claim.
Preserving muscle matters, but strength and everyday function need their own measurements, as ageing studies and muscle-preserving drug trials show.
Brain-age scores and genetic findings offer intriguing clues, but decisions about brain health still depend on what studies actually measured.
Kidney markers and blood-pressure trials connect vascular health with cognitive ageing, but they support different conclusions about prevention.
Exercise, heat exposure and thyroid research reveal why longevity priorities should depend on demonstrated benefits, personal circumstances and what remains uncertain.
Human trials on fiber, vitamin C and NAD+ show how to distinguish a measurable biological change from a benefit that matters.
Better sleep starts with understanding your light exposure and the demands on your time, not simply counting minutes on your phone.
Vascular research connects heart and brain health, but established prevention, experimental therapies and personal tracking answer different questions.
Recent semaglutide and multivitamin studies reveal why longer survival, better function and younger biological clocks require different interpretations.
England’s new pharmacy cholesterol tests point to a bigger truth for everyone over 40; the risks that matter most are silent, measurable, and worth checking before symptoms appear.